Miromatrix
Miromatrix is a Minnesota-based biotechnology company that develops and commercializes bioengineered transplantable kidneys and livers for organ transplantation.
Business Model:
Revenue: $146.2k
Employees: 51-200
Rankings
Industries / Tags:
Detailed Miromatrix Information
Geographic Data
Address: 6455 Flying Cloud Drive
City: Eden Prairie
State: MN
Zip: 55344
Country: US
Financial Info
Stage:
series c
Raised Last:
$0
Raised Total:$71M
Social
Metrics
4,828,435Website Global Rank
1,777Website Monthly Traffic
Twitter Followers
Description
Miromatrix is a Minnesota-based biotechnology company that develops and commercializes bioengineered transplantable kidneys and livers for organ transplantation.
Contact Phone:
+19529426000
Contact Email:
Miromatrix went public on 6/24/2021 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
6/24/2021
IPO Valuation:
$164M
Ticker Symbol:
MIRO
IPO Price:
$9/share
Amount Raised:
$43M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 5/2014 | Venture Round | $6.1M | 5/2021 | Series C | 1 | - |
CareDx CareDx |
10/2013 | Venture Round | $16.1M | 7/2018 | Series B | $15.7M | 8/2015 | Series B | $23.3M | 5/2021 | Minority Stake | - | 7/2013 | Grant | 1 | $1M |
National Science Foundation National Science Foundation National Science Foundation National Science Foundation |
12/2011 | Venture Round | $2M | 7/2012 | Venture Round | 1 | $5.3M |
Brightstone Venture Capital Brightstone Venture Capital Brightstone Venture Capital Brightstone Venture Capital |
11/2019 | Grant | 1 | $2M |
National Institute of Diabetes and Digestive and Kidney Diseases National Institute of Diabetes and Digestive and Kidney Diseases |
6/2021 | IPO | $43.2M | 4/2020 | Debt | $350k |
U.S. Small Business Administration. |
10/2019 | Grant | $2M |
National Institute of Diabetes and Digestive Kidney Diseases |
8/2021 | Series C | - |
CareDx DaVita CareDx DaVita |
5/2021 | Minority Stake | - |
CareDx CareDx |
5/2021 | Series C | 1 | - |
CareDx CareDx |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
